Off-Patent Biological and Biosimilar Medicines in Belgium:A Market Landscape Analysis
Background and objective: Best-value biological medicines may generate competition in the off-patent biologicals market, resulting in having more resources available to provide patients with access to necessary medicines while maintaining high-quality care. Belgium is a country known to have low biosimilar market shares, suggesting a malfunctioning market for off-patent biologicals. This study aims to gain an in-depth understanding of the Belgian off-patent biologicals market, by looking at the evolution in volumes and costs of the relevant products in the market. Methods: This study included... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2021 |
Reihe/Periodikum: | Vandenplas , Y , Simoens , S , Van Wilder , P , Vulto , A G & Huys , I 2021 , ' Off-Patent Biological and Biosimilar Medicines in Belgium : A Market Landscape Analysis ' , Frontiers in Pharmacology , vol. 12 , 644187 . https://doi.org/10.3389/fphar.2021.644187 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26604973 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://pure.eur.nl/en/publications/d97237ad-1a60-4e33-83d1-52181945bc09 |